News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
13h
GlobalData on MSNPfizer and Astellas’ Xtandi improves OS as combination therapyPfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...
Pfizer Inc. (NYSE:PFE) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 1, GlobalNewswire reported ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
9h
Zacks Investment Research on MSNWill Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
The primary exposure was a first-trimester prescription fill of nitrofurantoin, TMP-SMX, fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin), and β-lactams to treat UTI. Any congenital ...
According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results